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Abstract: 
We report an early case of extramedullary, right maxillary sinus and nasal, plasmacytoma. The patient was a 27 years 
old female who presented with nasal bleeding and a nasal mass. Imaging studies showed opacities in the nasal cavity 
and the maxillary sinus but there was no bone involvement.  A biopsy from the nasal mass showed a plasmacytoma. 
She was investigated to rule out systemic disease. The investigations included; serum electrophoresis, urine analysis 
for Bence Jones proteins, bone marrow aspirates study and radiological skeletal survey. The results of all 
investigations were negative. After complete excision of the tumour endoscopically the patient was treated with 
adjuvant radiotherapy. She remained well, without recurrence or spread of the tumour at 4 years follow up. CTscans 
pre and postoperatively as well as H&E and Immunohistochemistry slides are presented. To our knowledge, this is 
the first case to be reported in Sudan.                                                                    
 
Introduction: 
Plasmacytomas are discrete neoplasms composed of monoclonal plasma cells in either bone or soft tissue. 
Plasmacytomas differ from multiple myeloma in which the lesions are disseminated in the skeletal system 
and is associated with myeloma protein in the blood and urine (1, 2, 3). In a simplified description 
plasmacytoma is divided into two groups: Plasmacytoma of the skeletal system (SBP) and Extramedullary 
plasmacytoma (EMP). Extramedullary plasmacytoma (EMP) is uncommon and represents about 3% of all 
plasma cell neoplasms. Almost 90% of EMP occurs in the head and neck area in the upper respiratory tract. 
The gastrointestinal tract is a very rare site of involvement of this neoplasm. (1, 2, 3) 
EMP accounts for 1% of all head and neck malignancies(4).Predilection sites are: the naso-maxillary region, 
nasopharynx, oropharynx an larynx, in that order of frequency (5).Males are affected more than females and 
around 95% of cases are above 40 years(6).  
Diagnostic criteria for extramedullary plasmacytoma (EMP) are (7): 
 Tissue biopsy showing monoclonal plasma cell histology.  
 Bone marrow plasma cell infiltration not exceeding 5% of all nucleated cells.  
 Absence of osteolytic bone lesions or other tissue involvement (no evidence of myeloma).  
 Absence of hypercalcemia or renal failure.  
 Low serum M protein concentration, if present. 
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Case presentation:  
A 27 year old lady presented to the ENT Clinic at Soba University Hospital with recurrent right side 
epistaxis for 7 months and right nasal obstruction of 3 months duration. Nasal endoscopy revealed dark-red 
fleshy mass in the right nasal cavity; the cervical lymph nodes were not palpable and there was no evidence 
of cranial nerves involvement. CT scan showed opaque right nasal cavity and partially opaque right 
maxillary sinus with conserved bone outlines and no evidence of bone erosion (Figure 1 A & B).  
She was further investigated to rule out systemic disease.  The investigations included; serum 
electrophoresis, urine analysis for Bence Jones proteins, bone marrow aspirates study and plain radiological 
skeletal survey. The results of all investigations were negative. 
. 
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Figure (1) A and B: Coronal views of CT scan of the nose and sinuses 
The patient underwent excisional biopsy via endoscopic approach under general anesthesia. The mass was 
completely excised with removal of surrounding periosteum and the inferior turbinate, the specimen was 
sent for histopathology. Sections of the mass showed sheets of mature plasma cells in a scanty stroma.  Few 
small lymphocytes were scattered in the lesion (Figure 2). Immunohistochemistry study of the mass was 
positive for IgG and negative for IgA, IgM, CD20 and CD3 (Figure 3).  
A diagnosis of plasmacytoma was made.  Postoperatively the patient was treated with external beam 
radiation as adjuvant therapy at the radiation and Isotope Centre-Khartoum. Follow up of the patient 
revealed no evidence of local recurrence or systemic disease four years following the initial diagnosis 
(Figure4). 
 
Discussion: 
Extramedullary plasmacytoma is a rare pathology in the head and neck region. It constitutes 4% of all 
nonepithelial tumors of the nose, paranasal sinuses and nasopharynx (8). It should be included in the 
differential diagnosis of patients who present with nasal bleeding due to a mass involving this area.  
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Figure (2):  Specimen histopathology: Haematoxylin and Eosin section X40 magnification 
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Figure (3):  Immunohistochemistry slides 
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Figure (4): CT scan of the nose and sinuses, four years after treatment 
 
The peak age of extramedullary plasmacytoma patients ranges between 60 to 70 years (9). Cases in younger 
age groups are uncommon. The youngest patient with plasmacytoma involving the maxillary sinus was a 
10 years old female (10). The case presented here is younger than the average age by 38 years.  
The radiology of this case showed partial opacity of right maxillary sinus and right nasal cavity with no 
bone erosion. This, along with absence of tumour at other sites including the bone marrow, shows that the 
tumour in our patient satisfies the criteria for diagnosis of extramedullary plasmacytoma. To our 
knowledge, this is the first case to be reported in Sudan. 
The fact that EMP can be associated with or progresses to multiple myeloma necessitates other 
investigations to exclude systemic disease. Follow up should continue for at least 10 years as progression 
to multiple myeloma occurs in up to 36% of cases (11). 
Although EMP is radiosensitive, the combination of surgery and radiation therapy is advocated by many 
authors (12, 13). In the present case, endoscopic surgery was satisfactory, nevertheless adjuvant radiotherapy 
was offered to the patient to eliminate a possible microscopic residue. Nodal involvement and a tumour 
exceeding 5 cm indicate poor prognosis (14). Good prognosis is expected for the present case as the tumour 
is small, localised and is not associated with nodal involvement. These are the three important prognostic 
factors.  
 
Conclusion:  
Extramedullary plasmacytoma is a localised form of plasmacytoma. The present case is unique in that she 
is a female and being 38 years younger than the average age for the tumour.Treatment of EMP includes 
surgery and radiotherapy. It carries good prognosis if diagnosed at an early stage. Follow up is of paramount 
importance in order to detect local recurrence and/or distant metastasis.  
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